NASDAQ
Aardvark Therapeutics, Inc. Common Stock (AARD) has a current ratio of 10.61x as of Monday, May 25, 2026. This represents a 36.69% decrease compared to its 12-month average of 16.76x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.